Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Frederich, Robert
41  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Effects of Ertugliflozin on Kidney Outcomes in Patients Wit..:

Cherney, David Z.I ; Cosentino, Francesco ; McGuire, Darren K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105061/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Imputation of Missing Data for Time-to-Event Endpoints Usin..:

Wang, Shuai ; Frederich, Robert ; Mancuso, James P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10764582/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Efficacy and Safety of Ertugliflozin Added to Metformin: A ..:

Ji, Linong ; Liu, Jie ; Xu, Zhi Jin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944172/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Heart and Kidney Outcomes With Ertugliflozin in People with..:

Cherney, David Z.I ; Dagogo-Jack, Samuel ; Cosentino, Francesco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366295/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

Ertugliflozin, renoprotection and potential confounding by ..:

Cherney, David Z. I ; Charbonnel, Bernard ; Cosentino, Francesco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960556/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Effects of ertugliflozin on kidney composite outcomes, rena..:

Cherney, David Z. I ; Charbonnel, Bernard ; Cosentino, Francesco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099851/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Efficacy and Safety of Ertugliflozin in Patients with Type ..:

Budoff, Matthew J ; Davis, Timothy M. E ; Palmer, Alexandra G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099972/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Ertugliflozin and Slope of Chronic eGFR: Prespecified Analy..:

Cherney, David Z.I ; Cosentino, Francesco ; Dagogo-Jack, Samuel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729577/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Kidney outcomes using a sustained ≥40% decline in eGFR: A m..:

Cherney, David Z. I ; Dagogo‐Jack, Samuel ; McGuire, Darren K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364727/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Efficacy and Safety of Ertugliflozin in Patients with Type ..:

Budoff, Matthew J ; Davis, Timothy ME ; Palmer, Alexandra G...
qt5z55v6kd.  , 2021
Link: https://escholarship.org..
 
?
11

Efficacy of Ertugliflozin on Heart Failure–Related Events i..:

Cosentino, Francesco ; Cannon, Christopher P ; Cherney, David Z.I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717477/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

Effects of ertugliflozin on renal function over 104 weeks o..:

Cherney, David Z. I ; Heerspink, Hiddo J. L ; Frederich, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228910/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Safety of Ertugliflozin in Patients with Type 2 Diabetes Me..:

Patel, Shrita ; Hickman, Anne ; Frederich, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261307/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

A randomized controlled trial of the efficacy and safety of..:

White, Judith L ; Buchanan, Patricia ; Li, Jia.
http://www.biomedcentral.com/1472-6823/14/17.  , 2014
Link: http://www.biomedcentral..
 
?
15

Tolerability and efficacy of glycemic control with saxaglip..:

Karyekar, Chetan S ; Ravichandran, Shoba ; Allen, Elsie..
info:eu-repo/semantics/altIdentifier/doi/10.2147/CIA.S41246.  , 2013
Link: https://www.dovepress.co..
 
1-15